NeoGenix Extraction Allograft offers predictable outcomes and is an affordable alternative to traditional xenografts and synthetic products. (Image: Maria Sbytova/Shutterstock)
ZURICH, Switzerland: Neoss, a leading innovator in dental implant solutions and digital workflows, has launched NeoGenix Extraction Allograft, extending its line of biomaterials. Made of 100% human allograft bone fibre and bone particulate, it is designed to simplify bone regeneration for dental practitioners by offering a one-step solution that is effective and streamlined and aims to enhance patient outcomes.
NeoGenix Extraction Allograft incorporates a precise blend of demineralised bone fibre and mineralised bone particulate. (Image: Neoss)
NeoGenix Extraction Allograft incorporates a precise blend of demineralised bone fibre and mineralised bone particulate. By combining both cortical and cancellous materials into a convenient plug shape, the allograft creates an optimal environment for stronger and faster bone growth. This innovative composition eliminates the need for mixing particulate grafts or additionally applying a membrane, making the process more efficient and less complex for clinicians.
John Chopack, managing director of Neoss in the US, expressed his excitement about the product: “We are pleased to offer a new allograft fibre for extraction sites that not only delivers cost-effective results but also fosters faster, stronger bone growth. This helps preserve the integrity of the patient’s bone structure, ensuring that practitioners can keep future implant treatment options open, providing patients with a reliable foundation for long-term dental health.”
NeoGenix Extraction Allograft offers predictable and reliable outcomes, making it a trustworthy and affordable alternative to traditional xenografts and synthetic products. With its focus on ease of use and clinical effectiveness, NeoGenix Extraction Allograft provides dental professionals with a seamless, one-step solution to support high-quality patient care.
Visit the Neoss website for more information about NeoGenix Extraction Allograft.
WALTHAM, Mass., US: Neoss Group has recently announced the appointment of John Chopack as managing director of Neoss USA. Chopack joined Neoss Group in ...
BRUSSELS, Belgium: Neoss Group is proud to announce that it has received EU Medical Device Regulation (MDR) certification for its implants and abutments. ...
BERLIN, Germany: Neoss Group, a leading innovator in dental implant solutions, has launched the fast and easy-to-use wireless intra-oral scanner NeoScan ...
ZURICH, Switzerland: Neoss Group, a leading innovator in dental implant solutions, is proud to announce the launch of a new multi-unit abutment for its ...
HARROGATE, England: Neoss Group has recently announced that it has obtained certification under Regulation (EU) 2017/745 (Medical Device Regulation—MDR) ...
ZURICH, Switzerland: Neoss Group is delighted to announce that Sandra von Schmudde has assumed the role of managing director of Neoss today. She will be ...
ZURICH, Switzerland: Neoss Group, a pioneer in dental implant solutions, has announced its new partnership with Osstell, a global organisation headquartered...
To post a reply please login or register